Skip to content
Axcess News – Lifestyle
Author:
LENZ Therapeutics, Inc.
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
March 17, 2026
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
March 10, 2026
LENZ Therapeutics to Present at Upcoming Investor Conferences
March 5, 2026
←
Previous Page
1
2